Prevalence and Characteristics of HPV Vaccine Hesitancy Among Parents of Adolescents Across the US

dc.contributor.authorSzilagyi, Peter G.
dc.contributor.authorAlbertin, Christina S.
dc.contributor.authorGurfinkel, Dennis
dc.contributor.authorSaville, Alison W.
dc.contributor.authorVangala, Sitaram
dc.contributor.authorRice, John D.
dc.contributor.authorHelmkamp, Laura
dc.contributor.authorZimet, Gregory D.
dc.contributor.authorValderrama, Rebecca
dc.contributor.authorBreck, Abigail
dc.contributor.authorRand, Cynthia M.
dc.contributor.authorHumiston, Sharon G.
dc.contributor.authorKempe, Allison
dc.contributor.departmentPediatrics, School of Medicine
dc.date.accessioned2023-09-05T12:07:14Z
dc.date.available2023-09-05T12:07:14Z
dc.date.issued2020
dc.description.abstractBackground: While many clinicians encounter parents or adolescents who refuse HPV vaccine, little is known about the prevalence of hesitancy for HPV vaccine nationally or its association with vaccination. Methods: In April 2019, we surveyed families with adolescents 11-17 years using a national online panel (Knowledge Panel®) as the sampling frame. We assessed the prevalence of HPV vaccine hesitancy with the validated 9-item Vaccine Hesitancy Scale (VHS). We used multivariate analyses to assess demographic factors associated with HPV vaccine hesitancy. We also assessed practical barriers to receipt of HPV vaccine and the relationship between barriers and hesitancy. Finally, we evaluated the association between both HPV vaccine hesitancy and practical barriers on HPV vaccine receipt or refusal. Results: 2,177 parents out of 4,185 sampled (52%) completed the survey, 2,020 qualified (lived with adolescent). Using a VHS cut-off score > 3 out of 5 points, 23% of US parents were hesitant about HPV vaccine. Hesitancy was lower among those with Hispanic ethnicity. At least one out of five parents disagreed that the HPV vaccine is beneficial for their adolescent, that the vaccine is effective, protects against HPV-related cancers, or that they followed their adolescent's health-care provider's recommendation about the vaccine. Many were concerned about vaccine side effects and the novelty of the vaccine. Adolescents living with vaccine-hesitant parents were less than one-third as likely to have received the vaccine (RR = 0.29, 95% CI 0.24, 0.35) or completed the vaccine series (RR = 0.29, 95% CI 0.23, 0.36), and were 6-fold more likely to have refused the vaccine because of parental vaccine-related concerns (RR = 6.09, 95% CI = 5.26, 7.04). Most practical barriers were independently associated with vaccine receipt but not with vaccine refusal. Conclusions: HPV vaccine hesitancy is common nationally and strongly related to both under-vaccination and vaccine refusal.
dc.eprint.versionAuthor's manuscript
dc.identifier.citationSzilagyi PG, Albertin CS, Gurfinkel D, et al. Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the US. Vaccine. 2020;38(38):6027-6037. doi:10.1016/j.vaccine.2020.06.074
dc.identifier.urihttps://hdl.handle.net/1805/35368
dc.language.isoen_US
dc.publisherElsevier
dc.relation.isversionof10.1016/j.vaccine.2020.06.074
dc.relation.journalVaccine
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectHPV vaccine
dc.subjectVaccine hesitancy
dc.subjectPapillomavirus infections
dc.subjectVaccination refusal
dc.titlePrevalence and Characteristics of HPV Vaccine Hesitancy Among Parents of Adolescents Across the US
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
nihms-1618849.pdf
Size:
2.25 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: